Found 88 matching trials
Open-Label Study of H5 Vaccine in Participants of Protocol 04-077 PHASE1 This study may provide safety information on a flu vaccine given to childre...
Show More Location
UCLA Center For Vaccine Research
Learn More & Join Trial
Sanofi 2017 H7N9 With/Without AS03 in Adults/Elderly PHASE2 This is a randomized, double-blinded, Phase II study in healthy males and n...
Show More Location
The Hope Clinic of Emory University
Learn More & Join Trial
Randomized, Double Blinded, Placebo Control Clinical Trial of Pandemic Influenza Inactive Vaccine on Healthy Subjects PHASE1 Based on pre-clinical trial data and principle of GCP, the objective of pha...
Show More Location
China-Japan Friendship Hospital
Learn More & Join Trial
Booster Trial to 07-0019 With A/Anhui/05 With and Without MF59 PHASE1 This research will study safety and the body's immune (defense system) resp...
Show More Location
Emory Children's Center - Pediatric Infectious Diseases
Learn More & Join Trial
Inactivated Influenza A/H5N1 Vaccine in Adult Subjects at Risk of Occupational Exposure to Live H5N1 Viruses NA This is a single center, open-label, Phase I/II study in up to 100 adult su...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Immunogenicity of Two Doses of Monovalent Inactivated Influenza Vaccine That is Adjuvanted With MF59C.1 (MF59) and Uses a Surface Antigen From a Potential Pandemic Virus Strain Candidate (H5N1) in Adult and Elderly Subjects Using Four Different Vaccination Schedules PHASE3 The present study will evaluate the immunogenicity, safety and immunogenici...
Show More Location
Vaccination and Travel Medicine Centre
Learn More & Join Trial
Safety and Immunogenicity Study of Two Doses of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived) PHASE1 The objectives of this Phase I/II study are to assess the safety and immuno...
Show More Location
University of Hong Kong, Queen Mary Hospital
Learn More & Join Trial
Open-label Study to Assess Immunogenicity and Safety of a Vaccine Enhancement Patch When Administered With 2 Doses of H5N1 Vaccine PHASE1 Groups 1 to 3 will receive two vaccinations on Day 0 and Day 21. Group 1 wi...
Show More Location
Privatklinik Leech
Learn More & Join Trial
Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults PHASE1 H7N9 avian influenza (AI) viruses have caused a recent outbreak of severe r...
Show More Location
University of Rochester Medical Center
Learn More & Join Trial
Immunogenicity and Safety of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Adults PHASE2 The trial is a Phase II, open-label trial in healthy subjects aged 18 to 60...
Show More Location
Multiple Locations
Learn More & Join Trial